Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy

Johannes Pöhlmann,1 Roberta Montagnoli,2 Giusi Lastoria,3 Witesh Parekh,4 Marie Markert,5 Barnaby Hunt1 1Health Economics, Ossian Health Economics and Communications, Basel 4051, Switzerland; 2External Affairs-Region Europe, Novo Nordisk SpA, Rome IT00144, Italy; 3Medical Advice, Novo Nordisk S...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Pöhlmann J, Montagnoli R, Lastoria G, Parekh W, Markert M, Hunt B
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2019-10-01
coleção:	ClinicoEconomics and Outcomes Research
Assuntos:	Cost-effectiveness Fixed-ratio combination IDegLira iGlarLixi Italy Type 2 diabetes
Acesso em linha:	https://www.dovepress.com/value-for-money-in-the-treatment-of-patients-with-type-2-diabetes-mell-peer-reviewed-article-CEOR
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!